急性冠脉综合征实验室诊断指标研究进展  

Research Progress of Biological Indicators for Acute Coronary Syndromes

作　　者：赵树清[1] 

机构地区：[1]天津市安宁医院检验科,天津300300

出　　处：《中国城乡企业卫生》2015年第5期27-29,共3页Chinese Journal of Urban and Rural Enterprise Hygiene

摘　　要：急性冠脉综合征(acute coronary syndromes,ACS)是一种临床常见的严重心血管疾病,是以冠状动脉粥样硬化斑块破裂或侵蚀,继发形成完全或不完全闭塞性血栓为病理基础的临床综合征,包括急性ST段抬高性心肌梗死(STEMI)、急性非ST段抬高性心肌梗死(NSTEMI)和不稳定型心绞痛(UA),其典型表现为发作性胸痛、胸闷伴左臂放射性疼痛等,具有发病急、变化快、早期症状不明显等特点。近年来,ACS的发病率和死亡率均逐年上升,因此,寻找更加灵敏且特异的ACS实验室早期诊断指标,实现早诊断、早治疗,对降低患者病死率,减少并发症,改善预后具有重要意义。故本文对几类急性冠脉综合征实验室诊断指标予以综述,旨在为ACS的早期诊断、治疗及判断预后提供帮助。Acute Coronary Syndromes is the frequent and serious cardiovascular diseases in clinical,that Pathological basis is coronary atherosclerotic plaques rupture or erosion and formation of complete or incomplete occlusive thrombus. ACS include ST-segment elevation myocardial infarction（STEMI）,non-ST segment elevation myocardial infarction（NSTEMI） and unstable angina pectoris（UA）. Its typical performance is chest pain,chest stufly with left arm pain radioactivity and its onset quickly,rapid progression,characteristic not obvious. The morbidity and mortality of ACS are increasing in recent years. So searching the more sensitive and specific indicators for ACS early diagnosis,and avoid delay treatment and reduce mortality is important. This paper gives an overview of diagnostic indicators for diagnosis,treatment and prognosis of ACS early.

关 键 词：急性冠脉综合征 实验室诊断 生物指标 

分 类 号：R446.1[医药卫生—诊断学]